KASEY HOLLANDSWORTH: Open Payments
NPI 1356894554 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,083 in 117 payments from 19 companies in 2025. Trend: 2023 $689 · 2024 $1,430 · 2025 $2,083
Food & beverage: $1,917Education: $166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $490 |
| Janssen Biotech, Inc. | 15 | $274 |
| Galderma Laboratories, L.P. | 17 | $245 |
| Regeneron Healthcare Solutions, Inc. | 5 | $179 |
| UCB, Inc. | 7 | $159 |
| GENZYME CORPORATION | 7 | $139 |
| Incyte Corporation | 5 | $110 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Arcutis Biotherapeutics, Inc. | 3 | $66 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, NEMLUVIO, Bimzelx, OPZELURA, COSENTYX, Zoryve.
Industry payments across AZ — which companies pay providers there.
